Arkolith/Insider Trading/AZYO/Form 4

Mills C Randal

PRESIDENT AND CEO, DirectorAZIYO BIOLOGICS, INC. (AZYO) · full profile →Form 4 · filed Jun 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 21, 2023Option exercise(M)22K——70K
Jun 21, 2023Tax withholding(F)8K$2.41$19K63K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 21, 2023Option exercise(M)22K—$067K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-010225) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML